PharmaShots | Incisive News in 3 Shots

Subscribe Now

ALK + Metastatic Non-Small Cell

Takeda's Alunbrig (brigatinib) Receives the US FDA's Priority Review to Treat ALK + Metastatic Non-Small Cell Lung Cancer

Takeda's Alunbrig (brigatinib) Receives the US FDA's Priority Review to Treat ALK + Metastatic Non-Small Cell Lung Cancer

February 25, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us